OKYO Pharma OKYO
NASDAQ OKYO
$1.44 +0.12 (+9.09%)
As of: Oct 2, 2026 · 3:32 PM EDT

OKYO Pharma (OKYO) Depreciation & Amortization (CF) (2023 - 2026)

Updated

OKYO Pharma's Depreciation & Amortization (CF) was -$743 million in the quarter ended Mar 31, 2026.

Analysis

OKYO Pharma (OKYO) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends

For the year ended Mar 31, 2026, Depreciation & Amortization (CF) at OKYO Pharma came in at $1.82 billion, down 29.0% from the prior year.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -1.6% (years ended Mar 2021 to Mar 2026).
  • In earlier years, Depreciation & Amortization (CF) was $2.56 billion in the year ended Mar 31, 2025, $3.87 billion in the year ended Dec 31, 2024 (+1.8%), $3.8 billion in the year ended Dec 31, 2023 and $3.19 billion in the year ended Mar 31, 2022 (+61.3%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 OKYO Pharma 867.87 Mn 867.87 Mn - -743.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -743.00 Mn
Dec 31, 2025 2.56 Bn
Sep 30, 2023 -2,995.00
API Access

OKYO Pharma Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=OKYO&period=max&api_key=YOUR_API_KEY